GlycoNet Investigator is developing a gel-based drug delivery system with a massive potential.
Catégorie : Network News
As the new year approaches, here is a look back at some of the most exciting advances from GlycoNet researchers in 2019.
GlycoNet Investigators are looking into using carbohydrate-binding proteins to help battle fungal pathogens.
GlycoNet scientists solved the structure of an enzyme that could help burn victims and prevent deaths from different kinds of infections.
GlycoNet Investigator sets the stage for new therapeutic strategies for Alzheimer’s disease.
GlycoNet researchers discovered a molecule against Methicillin-resistant (MRSA) bacteria.
GlycoNet scientists identified an enzyme possibly related to bacterial virulence and antibiotic resistance.
The direct biochemical approach helps direct cells to specific sites for more efficient and targeted treatment.
Glycoscience expert Warren Wakarchuk is a Professor and Associate Scientific Director of the Canadian Glycomics Network
Four Network trainees will participate in the conference where they will be exposed to a wide spectrum of topics and pressing issues in science and innovation policy